Private Trust Co Has Upped Dow Chemical Co. (DOW) Stake; Nanostring Technologies (NSTG)’s Sentiment Is 1.67

November 15, 2017 - By Richard Conner

Private Trust Co increased Dow Chemical Co. (DOW) stake by 24.67% reported in 2017Q2 SEC filing. Private Trust Co acquired 5,607 shares as Dow Chemical Co. (DOW)’s stock rose 0.05%. The Private Trust Co holds 28,336 shares with $1.79M value, up from 22,729 last quarter. Dow Chemical Co. now has $83.74B valuation. It is 0.00% or $0 reaching $66.65 per share. It is down 20.72% since November 15, 2016 and is uptrending. It has outperformed by 4.02% the S&P500.

NanoString Technologies, Inc. develops, makes and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The company has market cap of $201.29 million. The Firm is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. It currently has negative earnings. The Company’s nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology.

Among 16 analysts covering The Dow Chemical Company (NYSE:DOW), 10 have Buy rating, 1 Sell and 5 Hold. Therefore 63% are positive. The Dow Chemical Company had 48 analyst reports since August 20, 2015 according to SRatingsIntel. The stock has “Buy” rating by Deutsche Bank on Friday, October 23. The stock has “Buy” rating by Alembic on Thursday, July 27. The firm earned “Neutral” rating on Monday, April 18 by Citigroup. On Tuesday, September 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was upgraded by Citigroup to “Buy” on Monday, October 3. The stock of Dow Chemical Co (NYSE:DOW) earned “Neutral” rating by UBS on Tuesday, December 15. The firm earned “Hold” rating on Monday, August 28 by Cowen & Co. The stock of Dow Chemical Co (NYSE:DOW) has “Top Pick” rating given on Wednesday, February 3 by RBC Capital Markets. The stock of Dow Chemical Co (NYSE:DOW) earned “Outperform” rating by Credit Suisse on Thursday, March 24. The rating was maintained by RBC Capital Markets on Thursday, July 27 with “Buy”.

Investors sentiment increased to 1.09 in 2017 Q2. Its up 0.03, from 1.06 in 2017Q1. It is positive, as 44 investors sold DOW shares while 407 reduced holdings. 101 funds opened positions while 392 raised stakes. 809.06 million shares or 1.28% less from 819.57 million shares in 2017Q1 were reported. Croft holds 0.05% or 3,325 shares in its portfolio. Nbt Bancorporation N A New York has invested 0.31% in Dow Chemical Co (NYSE:DOW). Ironwood Limited Liability accumulated 1,739 shares or 0.07% of the stock. Prudential invested in 1.70M shares or 0.16% of the stock. The Missouri-based Buckingham Asset Ltd has invested 0.08% in Dow Chemical Co (NYSE:DOW). Sun Life Financial Incorporated, Ontario – Canada-based fund reported 11,205 shares. Principal Grp Incorporated has 0.17% invested in Dow Chemical Co (NYSE:DOW) for 2.67M shares. Jfs Wealth Advsr Limited Liability reported 0% stake. Loomis Sayles Ltd Partnership stated it has 17,753 shares. Geneva Advisors Limited Liability Com has 4,341 shares. Barnett And Inc invested in 0.02% or 600 shares. Orleans Capital Mgmt Corp La has 2.62% invested in Dow Chemical Co (NYSE:DOW). Thompson Siegel And Walmsley Limited Liability Company accumulated 34,827 shares. Conning Inc has invested 1.25% in Dow Chemical Co (NYSE:DOW). Confluence Inv Management Ltd Limited Liability Company reported 0.02% stake.

Analysts await NanoString Technologies Inc (NASDAQ:NSTG) to report earnings on March, 7. They expect $-0.48 earnings per share, up 12.73% or $0.07 from last year’s $-0.55 per share. After $-0.45 actual earnings per share reported by NanoString Technologies Inc for the previous quarter, Wall Street now forecasts 6.67% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com